Fish & Richardson Secures Win for Exela Pharma Sciences in ELCYS® Patent Infringement Litigation
Fish & Richardson Trademark & Copyright Thoughts
AUGUST 15, 2022
At trial, which lasted three days, a Fish team led by Drakulich successfully proved infringement of the third patent, and rebuffed Eton’s claims that the patents were both anticipated and obvious based on prior art products which exhibited the very problems Exela set out to, and did, solve. Eton Pharmaceuticals, Inc.,
52 
Let's personalize your content